Price to Sales ratio Analysis of Teva Pharma Industries Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Good PS
1.21
Period Ending - Dec-22
Good PS
1.28
Growth
-5.05 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Good PS
1.21
PS Analysis of Teva Pharma Industries Ltd.
| P/S Ratio 1.21 of Teva Pharma Industries Ltd. indicates that stock price is low compared to sales of the company and may be undervalued. |
| PS Ratio of TEVA has fallen by -5.05 % Compared to previous Financial Year. |
| PS Ratio with value of 1.28 was highest in Year Dec-22 in last Five Years. |
| PS Ratio with value of 1.11 was lowest in Year Dec-19 in last Five Years. |
| Latest PS Ratio with value of 1.21 is Greater than Average PS of 1.18 in last five years. |
Other PS Related Info of TEVA that may interest you.
Teva Pharma Industries Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| TEVA | 17.16 | 17.4 | 1.38 % | Drug Manufacturers-Specialty & Generic |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Low Value Stock | |
FY - Historical Price to Sales of Teva Pharma Industries Ltd.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 1.21 | 1.28 | 1.20 | 1.13 | 1.11 | 0.929 | 0.779 |
| Change | -5.05 % | 6.68 % | 6.06 % | 1.75 % | 19.30 % | 19.31 % | 3.45 % |
FY Chart of Price to Sales of Teva Pharma Industries Ltd.
Note : All Data Generated at the End of Trading Hours (EOD Data)